Aki Morikawa
Impact in
Papers in
-
- Brain Metastases and Treatment 28
- Lung Cancer Treatments and Mutations 10
- Advanced Breast Cancer Therapies 6
- Oncology 29
- Cancer Treatment and Pharmacology 11
- Lung Cancer Research Studies 11
- HER2/EGFR in Cancer Research 7
- Co-authors
- Andrew D. Seidman (13 shared papers)Sujata Patil (8 shared papers)N. Lynn Henry (1 shared paper)Elena Pentsova (4 shared papers)Ian E. Krop (4 shared papers)Nancy U. Lin (5 shared papers)Sarat Chandarlapaty (3 shared papers)Jennie R. Crews (2 shared papers)
- Journals
- Journal of Clinical Oncology (12 papers)Cancer Research (6 papers)International Journal of Radiation Oncology*Biology*Physics (3 papers)Neuro-Oncology (3 papers)Clinical Cancer Research (2 papers)
- Partner nations
- United StatesUnited KingdomJapan
In The Last Decade
Aki Morikawa
46 papers receiving 784 citations
Aki Morikawa's Hit Papers
Peers
Comparison fields: 5 of 72
- Genetics 202
- Oncology 498
- Pulmonary and Respiratory Medicine 462
- Cancer Research 141
- Radiology, Nuclear Medicine and Imaging 95
Countries citing papers authored by Aki Morikawa
This map shows the geographic impact of Aki Morikawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aki Morikawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aki Morikawa more than expected).
Fields of papers citing papers by Aki Morikawa
This network shows the impact of papers produced by Aki Morikawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aki Morikawa. The network helps show where Aki Morikawa may publish in the future.
Co-authors
The 25 scholars most cited alongside Aki Morikawa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 132 | |
| 2 | Systemic Therapy for Advanced Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: ASCO Guideline Update Hit paper breakdown → | 2022 | 116 |
| 3 | 2016 | 78 | |
| 4 | 2019 | 43 | |
| 5 | 2022 | 41 | |
| 6 | 2019 | 35 | |
| 7 | 2015 | 32 | |
| 8 | 2021 | 31 | |
| 9 | 2022 | 29 | |
| 10 | 2014 | 25 | |
| 11 | 2006 | 24 | |
| 12 | 2021 | 23 | |
| 13 | 2024 | 17 | |
| 14 | 2019 | 15 | |
| 15 | 2002 | 14 | |
| 16 | 2003 | 13 | |
| 17 | 2005 | 12 | |
| 18 | 2017 | 11 | |
| 19 | 2013 | 11 | |
| 20 | 2021 | 10 |
About Aki Morikawa
Aki Morikawa is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Genetics, Cancer Research and Radiology, Nuclear Medicine and Imaging, having authored 49 papers that have together received 794 indexed citations. Recurring topics across this work include Brain Metastases and Treatment (28 papers), Cancer Treatment and Pharmacology (11 papers), Lung Cancer Research Studies (11 papers), Glioma Diagnosis and Treatment (11 papers), Lung Cancer Treatments and Mutations (10 papers), HER2/EGFR in Cancer Research (7 papers), Radiopharmaceutical Chemistry and Applications (7 papers) and Advanced Breast Cancer Therapies (6 papers). The work is most often cited by research in Genetics (202 citations), Oncology (498 citations), Pulmonary and Respiratory Medicine (462 citations), Cancer Research (141 citations) and Radiology, Nuclear Medicine and Imaging (95 citations). Aki Morikawa has collaborated with scholars based in United States, United Kingdom and Japan. Frequent co-authors include Andrew D. Seidman, Sujata Patil, N. Lynn Henry, Elena Pentsova, Ian E. Krop, Nancy U. Lin, Sarat Chandarlapaty, Jennie R. Crews, Paul R. Lockman and Sarah Temin. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, International Journal of Radiation Oncology*Biology*Physics, Neuro-Oncology and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.